Vivos Therapeutics (VVOS) Free Cash Flow (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Free Cash Flow of -$6.0 million for Q1 2026, down 53.44% year-over-year from -$12.9 million in Q1 2025, and up 26.05% quarter-over-quarter from -$8.1 million in Q4 2025.
Vivos Therapeutics (VVOS) Free Cash Flow (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Free Cash Flow for 7 consecutive years, with -$6.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow fell 53.44% year-over-year to -$6.0 million; the TTM figure through Mar 2026 stood at -$22.5 million (down 55.23% YoY), while the FY2025 annual figure was -$20.4 million, down 54.12% from the prior year.
- Free Cash Flow climbed to -$6.0 million in Q1 2026 per VVOS's latest filing, from -$8.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$2.4 million in Q3 2023 and bottomed at -$8.1 million in Q4 2025.
- Historically, Free Cash Flow has averaged -$4.3 million across 5 years, with a median of -$3.9 million in 2025.
- Annual changes were most pronounced in 2023 — Free Cash Flow jumped 60.18% — and 2025, when it slumped 161.34%.
- Vivos Therapeutics' Free Cash Flow stood at -$3.2 million in 2022, then retreated by 7.53% to -$3.5 million in 2023, then gained by 9.87% to -$3.1 million in 2024, then plunged by 161.34% to -$8.1 million in 2025, then rose by 26.05% to -$6.0 million in 2026.
- Business Quant data shows VVOS's Free Cash Flow at -$6.0 million in Q1 2026, -$8.1 million in Q4 2025, and -$4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | -3.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.02 Mn |
| Mar 31, 2026 | -6.02 Mn |
| Dec 31, 2025 | -8.14 Mn |
| Dec 31, 2025 | -8.14 Mn |
| Sep 30, 2025 | -4.12 Mn |
| Sep 30, 2025 | -4.12 Mn |
| Jun 30, 2025 | -4.27 Mn |
| Jun 30, 2025 | -4.27 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | -4.34 Mn |
| Sep 30, 2024 | -4.34 Mn |
| Jun 30, 2024 | -3.14 Mn |
| Jun 30, 2024 | -3.14 Mn |
| Mar 31, 2024 | -2.67 Mn |
| Mar 31, 2024 | -2.67 Mn |
| Dec 31, 2023 | -3.46 Mn |
| Dec 31, 2023 | -3.46 Mn |